Cancer BiologybioRxivPreprint
KLIPP - a precision CRISPR approach to target structural variant junctions in cancer
H. Yang, R. S. Hulbatte, A. Kellher…·M. Ljungman
KLIPP uses CRISPR/Cas9 to target cancer-specific structural variant junctions, inducing DNA breaks and cell death in tumor cells with high specificity.
DOI 10.1101/2023.05.10.540176